
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery Platform
Sponsor : Serum Institute of India
Deal Size : Undisclosed
Deal Type : Collaboration
Primrose, Serum Institute Collaborate on Novel Multi-Antigen Vaccine Development
Details : The companies will contribute towards the design of the vaccine with Primrose fully responsible for developing strains using its Pfenex Technology and SIIPL responsible for further commercialization.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
January 10, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery Platform
Sponsor : Serum Institute of India
Deal Size : Undisclosed
Deal Type : Collaboration
